|
Formoterol reduces muscle wasting in mice undergoing doxorubicin chemotherapy.
|
Front Oncol
38234397
|
0 |
4.7 |
2024 |
|
Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management.
|
Nat Rev Clin Oncol
36806788
|
16 |
78.8 |
2023 |
|
Effects of S-pindolol in mouse pancreatic and lung cancer cachexia models.
|
J Cachexia Sarcopenia Muscle
37130578
|
1 |
8.9 |
2023 |
|
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer.
|
Cancers (Basel)
36831431
|
4 |
5.2 |
2023 |
|
The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model.
|
J Cachexia Sarcopenia Muscle
36346141
|
3 |
8.9 |
2022 |
|
Effects of Cigarette Smoke on Adipose and Skeletal Muscle Tissue: In Vivo and In Vitro Studies.
|
Cells
36139468
|
5 |
6 |
2022 |
|
Lack of Synergy Between β-Agonist Treatment and a Blockage of Sarcoplasmic Calcium Flow in a Rat Cancer Cachexia Model.
|
Onco Targets Ther
33762827
|
0 |
4.345 |
2021 |
|
Win 55,212-2, atenolol and subdiaphragmatic vagotomy prevent acceleration of gastric emptying induced by cachexia via Yoshida-AH-130 cells in rats.
|
Eur J Pharmacol
32234430
|
3 |
4.432 |
2020 |
|
Laparoscopic Right Adrenalectomy in a Large Right Adrenal Oncocytic Carcinoma.
|
Ann Surg Oncol
33244737
|
0 |
4.339 |
2020 |
|
Labour accidents and financial performance: empirical analysis of the type of relationship in the Spanish context.
|
Int J Occup Saf Ergon
33198588
|
0 |
0.01 |
2020 |
|
Differential structural features in soleus and gastrocnemius of carnitine-treated cancer cachectic rats.
|
J Cell Physiol
31241186
|
7 |
6.384 |
2019 |
|
Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function.
|
J Mol Biol
31150737
|
40 |
4.76 |
2019 |
|
A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice.
|
Int J Mol Sci
31600911
|
3 |
4.556 |
2019 |
|
Mediators of cachexia in cancer patients.
|
Nutrition
31177056
|
28 |
3.769 |
2019 |
|
Cancer cachexia, a clinical challenge.
|
Curr Opin Oncol
30893144
|
9 |
3.336 |
2019 |
|
Therapeutic strategies against cancer cachexia.
|
Eur J Transl Myol
31019661
|
24 |
0 |
2019 |
|
The animal cachexia score (ACASCO).
|
Animal Model Exp Med
31773096
|
5 |
0 |
2019 |
|
Inter-tissue communication in cancer cachexia.
|
Nat Rev Endocrinol
30464312
|
101 |
24.646 |
2018 |
|
Effects of the beta agonist formoterol on atrophy signaling, autophagy, and muscle phenotype in respiratory and limb muscles of rats with cancer-induced cachexia.
|
Biochimie
29654866
|
21 |
3.418 |
2018 |
|
Editorial: Biological Mechanism-Based and Patient-Centered Management of Cancer-Related Symptoms and Syndromes.
|
Front Physiol
30618829
|
2 |
3.151 |
2018 |
|
Unifying diagnostic criteria for cachexia: An urgent need.
|
Clin Nutr
28238466
|
5 |
5.496 |
2017 |
|
Novel targeted therapies for cancer cachexia.
|
Biochem J
28751550
|
26 |
3.857 |
2017 |
|
A Rat Immobilization Model Based on Cage Volume Reduction: A Physiological Model for Bed Rest?
|
Front Physiol
28424626
|
6 |
3.325 |
2017 |
|
Validation of the CAchexia SCOre (CASCO). Staging Cancer Patients: The Use of miniCASCO as a Simplified Tool.
|
Front Physiol
28261113
|
19 |
3.325 |
2017 |
|
Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats.
|
PeerJ
29255650
|
14 |
2.118 |
2017 |
|
The Three Faces of Sarcopenia.
|
J Am Med Dir Assoc
27161851
|
5 |
5.775 |
2016 |
|
Skeletal Muscle Regulates Metabolism via Interorgan Crosstalk: Roles in Health and Disease.
|
J Am Med Dir Assoc
27324808
|
156 |
5.775 |
2016 |
|
The 2015 ESPEN Sir David Cuthbertson lecture: Inflammation as the driving force of muscle wasting in cancer.
|
Clin Nutr
27268093
|
11 |
5.496 |
2016 |
|
The assessment of productivity in biomedical research.
|
Ann Med
27649468
|
0 |
3.715 |
2016 |
|
A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy.
|
J Cachexia Sarcopenia Muscle
27066318
|
31 |
9.697 |
2015 |
|
Conversion of leucine to β-hydroxy-β-methylbutyrate by α-keto isocaproate dioxygenase is required for a potent stimulation of protein synthesis in L6 rat myotubes.
|
J Cachexia Sarcopenia Muscle
27065075
|
27 |
9.697 |
2015 |
|
Open source in cachexia?
|
J Cachexia Sarcopenia Muscle
26136418
|
0 |
9.697 |
2015 |
|
Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signalling.
|
J Cachexia Sarcopenia Muscle
26136415
|
20 |
9.697 |
2015 |
|
Request for regulatory guidance for cancer cachexia intervention trials.
|
J Cachexia Sarcopenia Muscle
26675232
|
57 |
9.697 |
2015 |
|
Experimental cancer cachexia: Evolving strategies for getting closer to the human scenario.
|
Semin Cell Dev Biol
26343953
|
34 |
6.614 |
2015 |
|
Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist.
|
Int J Cancer
26595367
|
30 |
6.513 |
2015 |
|
Cachexia and sarcopenia: mechanisms and potential targets for intervention.
|
Curr Opin Pharmacol
25974750
|
108 |
5.363 |
2015 |
|
Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations.
|
Oncotarget
26636649
|
54 |
5.008 |
2015 |
|
Muscle wasting in cancer: the role of mitochondria.
|
Curr Opin Clin Nutr Metab Care
25769061
|
32 |
4.023 |
2015 |
|
Nonmuscle Tissues Contribution to Cancer Cachexia.
|
Mediators Inflamm
26523094
|
22 |
3.232 |
2015 |
|
Cancer cachexia: understanding the molecular basis.
|
Nat Rev Cancer
25291291
|
519 |
37.147 |
2014 |
|
Cachexia: a problem of energetic inefficiency.
|
J Cachexia Sarcopenia Muscle
25118829
|
40 |
9.697 |
2014 |
|
Formoterol in the treatment of experimental cancer cachexia: effects on heart function.
|
J Cachexia Sarcopenia Muscle
25167857
|
23 |
9.697 |
2014 |
|
Distinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3.
|
PLoS One
25436606
|
14 |
3.706 |
2014 |
|
A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals dysregulation of excitation–contraction coupling together with additional muscle alterations.
|
Muscle Nerve
23649607
|
9 |
2.605 |
2014 |
|
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
|
Eur Heart J
23990596
|
88 |
20.212 |
2013 |
|
Hypothalamic food intake regulation in a cancer-cachectic mouse model.
|
J Cachexia Sarcopenia Muscle
24222472
|
12 |
9.697 |
2013 |
|
Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models.
|
J Lipid Res
23966665
|
12 |
4.81 |
2013 |
|
A new look at an old drug for the treatment of cancer cachexia: megestrol acetate.
|
Clin Nutr
23395103
|
17 |
4.548 |
2013 |
|
Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model.
|
Int J Oncol
23817738
|
53 |
3.079 |
2013 |
|
Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?
|
Biochim Biophys Acta
23200745
|
50 |
0 |
2013 |
|
Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways.
|
Gastroenterology
23142626
|
40 |
18.392 |
2012 |
|
Are there any benefits of exercise training in cancer cachexia?
|
J Cachexia Sarcopenia Muscle
22565649
|
47 |
9.697 |
2012 |
|
Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
|
Int J Cancer
22336965
|
26 |
6.513 |
2012 |
|
Myostatin: more than just a regulator of muscle mass.
|
Drug Discov Today
22342983
|
47 |
6.369 |
2012 |
|
L-Carnitine: an adequate supplement for a multi-targeted anti-wasting therapy in cancer.
|
Clin Nutr
22608917
|
18 |
4.548 |
2012 |
|
The potential of ghrelin in the treatment of cancer cachexia.
|
Expert Opin Biol Ther
23078025
|
15 |
3.684 |
2012 |
|
Mechanisms and treatment of cancer cachexia.
|
Nutr Metab Cardiovasc Dis
22749678
|
21 |
3.679 |
2012 |
|
Theophylline is able to partially revert cachexia in tumour-bearing rats.
|
Nutr Metab (Lond)
22909172
|
13 |
2.974 |
2012 |
|
A high fat diet in CF-1 mice: An experimental model for metabolic syndrome.
|
Mol Med Rep
21479424
|
2 |
1.692 |
2012 |
|
Counteracting inflammation: a promising therapy in cachexia.
|
Crit Rev Oncog
22831156
|
31 |
1.429 |
2012 |
|
The cachexia score (CASCO): a new tool for staging cachectic cancer patients.
|
J Cachexia Sarcopenia Muscle
21766054
|
60 |
9.697 |
2011 |
|
Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise.
|
J Cachexia Sarcopenia Muscle
21766055
|
40 |
9.697 |
2011 |
|
Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance.
|
J Cachexia Sarcopenia Muscle
22450815
|
62 |
9.697 |
2011 |
|
Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?
|
J Cachexia Sarcopenia Muscle
21475674
|
14 |
9.697 |
2011 |
|
Sarcopenia with limited mobility: an international consensus.
|
J Am Med Dir Assoc
21640657
|
337 |
5.775 |
2011 |
|
Anti-inflammatory therapies in cancer cachexia.
|
Eur J Pharmacol
21835173
|
33 |
2.896 |
2011 |
|
Cancer cachexia: physical activity and muscle force in tumour-bearing rats.
|
Oncol Rep
21109976
|
19 |
2.662 |
2011 |
|
Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice.
|
Oncol Rep
21503587
|
22 |
2.662 |
2011 |
|
Effects of formoterol on protein metabolism in myotubes during hyperthermia.
|
Muscle Nerve
21254094
|
3 |
2.605 |
2011 |
|
Interleukin-15 affects differentiation and apoptosis in adipocytes: implications in obesity.
|
Lipids
21894465
|
9 |
1.934 |
2011 |
|
Formoterol treatment downregulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats.
|
Oncol Lett
22740878
|
8 |
1.39 |
2011 |
|
Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity.
|
Exp Ther Med
22977567
|
8 |
1.261 |
2011 |
|
Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats.
|
Antioxid Redox Signal
19737087
|
30 |
6.337 |
2010 |
|
Consensus on cachexia definitions.
|
J Am Med Dir Assoc
20439040
|
44 |
5.775 |
2010 |
|
Nutritional recommendations for the management of sarcopenia.
|
J Am Med Dir Assoc
20627179
|
177 |
5.775 |
2010 |
|
Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting.
|
Clin Nutr
20655130
|
1 |
4.548 |
2010 |
|
Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".
|
Clin Nutr
20060626
|
503 |
4.548 |
2010 |
|
Megestrol acetate: its impact on muscle protein metabolism supports its use in cancer cachexia.
|
Clin Nutr
20621398
|
8 |
4.548 |
2010 |
|
Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status.
|
Obesity (Silver Spring)
20885391
|
37 |
3.873 |
2010 |
|
Patterns of gene expression in muscle and fat in tumor-bearing rats: effects of CRF2R agonist on cachexia.
|
Muscle Nerve
21104868
|
2 |
2.605 |
2010 |
|
Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.
|
Int J Mol Med
21069263
|
45 |
2.341 |
2010 |
|
Optimal management of cancer anorexia-cachexia syndrome.
|
Cancer Manag Res
21188094
|
16 |
0 |
2010 |
|
Direct effects of doxorubicin on skeletal muscle contribute to fatigue.
|
Br J Cancer
19165199
|
53 |
6.176 |
2009 |
|
Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice.
|
Br J Cancer
19259092
|
47 |
6.176 |
2009 |
|
Impaired immune function: an early marker for cancer cachexia.
|
Oncol Rep
19885593
|
11 |
2.662 |
2009 |
|
Interleukin-15 increases calcineurin expression in 3T3-L1 cells: possible involvement on in vivo adipocyte differentiation.
|
Int J Mol Med
19724884
|
14 |
2.341 |
2009 |
|
PPARdelta mediates IL15 metabolic actions in myotubes: effects of hyperthermia.
|
Int J Mol Med
19513536
|
4 |
2.341 |
2009 |
|
The role of cytokines in cancer cachexia.
|
Curr Opin Support Palliat Care
19713854
|
85 |
2.045 |
2009 |
|
Both AP-1 and NF-kappaB seem to be involved in tumour growth in an experimental rat hepatoma.
|
Anticancer Res
19414381
|
5 |
1.937 |
2009 |
|
Therapeutic potential of interleukin-15: a myokine involved in muscle wasting and adiposity.
|
Drug Discov Today
19041416
|
22 |
6.369 |
2008 |
|
Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia.
|
Br J Cancer
19018259
|
23 |
6.176 |
2008 |
|
Cachexia: a new definition.
|
Clin Nutr
18718696
|
776 |
4.548 |
2008 |
|
Oversecretion of interleukin-15 from skeletal muscle reduces adiposity.
|
Am J Physiol Endocrinol Metab
19001550
|
112 |
4.142 |
2008 |
|
Effects of IL-15 on rat brown adipose tissue: uncoupling proteins and PPARs.
|
Obesity (Silver Spring)
18239634
|
25 |
3.873 |
2008 |
|
UCP3 overexpression neutralizes oxidative stress rather than nitrosative stress in mouse myotubes.
|
FEBS Lett
19101552
|
13 |
3.623 |
2008 |
|
Apoptosis signalling is essential and precedes protein degradation in wasting skeletal muscle during catabolic conditions.
|
Int J Biochem Cell Biol
18329944
|
23 |
3.505 |
2008 |
|
Effects of the PPARgamma agonist GW1929 on muscle wasting in tumour-bearing mice.
|
Oncol Rep
18097603
|
4 |
2.662 |
2008 |
|
Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
|
Muscle Nerve
17912749
|
13 |
2.605 |
2008 |
|
Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.
|
Cancer Res
17616713
|
16 |
9.122 |
2007 |
|
Novel approaches to the treatment of cachexia.
|
Drug Discov Today
18190867
|
21 |
6.369 |
2007 |
|
Antiproteolytic effects of plasma from hibernating bears: a new approach for muscle wasting therapy?
|
Clin Nutr
17904252
|
20 |
4.548 |
2007 |
|
Protein breakdown on whole-body and organ level in non-cachectic tumour-bearing mice undergoing surgery.
|
Clin Nutr
17513024
|
1 |
4.548 |
2007 |
|
Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients.
|
Clin Nutr
17688974
|
28 |
4.548 |
2007 |
|
Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models.
|
Clin Nutr
17261345
|
16 |
4.548 |
2007 |
|
The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia.
|
Int J Oncol
17390027
|
16 |
3.079 |
2007 |
|
Emerging drugs for cancer cachexia.
|
Expert Opin Emerg Drugs
17979599
|
3 |
3.062 |
2007 |
|
Potassium channels are a new target field in anticancer drug design.
|
Recent Pat Anticancer Drug Discov
18221064
|
18 |
2.956 |
2007 |
|
Targets in clinical oncology: the metabolic environment of the patient.
|
Front Biosci
17485280
|
5 |
2.497 |
2007 |
|
Mechanisms to explain wasting of muscle and fat in cancer cachexia.
|
Curr Opin Support Palliat Care
18685378
|
14 |
2.045 |
2007 |
|
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy.
|
Biochim Biophys Acta
17442496
|
3 |
0 |
2007 |
|
Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity.
|
Endocr Rev
16556851
|
5 |
15.745 |
2006 |
|
Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model.
|
Cancer Lett
16466851
|
28 |
6.375 |
2006 |
|
The AP-1/CJUN signaling cascade is involved in muscle differentiation: implications in muscle wasting during cancer cachexia.
|
FEBS Lett
16412434
|
13 |
3.623 |
2006 |
|
IGF-1 is downregulated in experimental cancer cachexia.
|
Am J Physiol Regul Integr Comp Physiol
16614058
|
72 |
2.982 |
2006 |
|
BARD1 content correlates with increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.
|
Oncol Rep
16685375
|
4 |
2.662 |
2006 |
|
Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index.
|
Respiration
16825756
|
12 |
2.543 |
2006 |
|
Hemostasis alterations in metabolic syndrome (review).
|
Int J Mol Med
17016629
|
23 |
2.341 |
2006 |
|
[Physiology of sarcopenia. Similarities and differences with neoplasic cachexia (muscle impairments in cancer and ageing)].
|
Nutr Hosp
16768029
|
2 |
0.747 |
2006 |
|
[Pathophysiology of neoplasic cachexia].
|
Nutr Hosp
16768025
|
8 |
0.747 |
2006 |
|
Cytokines as mediators and targets for cancer cachexia.
|
Cancer Treat Res
16610709
|
14 |
0 |
2006 |
|
Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine.
|
Biochim Biophys Acta
17056184
|
36 |
0 |
2006 |
|
Muscle wasting in cancer and ageing: cachexia versus sarcopenia.
|
Adv Gerontol
16676797
|
16 |
0 |
2006 |
|
Effects of interleukin-15 on lipid oxidation: disposal of an oral [(14)C]-triolein load.
|
Biochim Biophys Acta
16458591
|
28 |
0 |
2006 |
|
Cross-talk between skeletal muscle and adipose tissue: a link with obesity?
|
Med Res Rev
15389734
|
53 |
8.763 |
2005 |
|
Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats.
|
FEBS Lett
15757655
|
50 |
3.623 |
2005 |
|
Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake. Involvement of ROS in a model of mouse cancer cachexia.
|
FEBS Lett
15670834
|
25 |
3.623 |
2005 |
|
The pivotal role of cytokines in muscle wasting during cancer.
|
Int J Biochem Cell Biol
15878837
|
10 |
3.505 |
2005 |
|
The pivotal role of cytokines in muscle wasting during cancer.
|
Int J Biochem Cell Biol
16105746
|
36 |
3.505 |
2005 |
|
Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation.
|
Int J Oncol
15870883
|
10 |
3.079 |
2005 |
|
Cancer cachexia results in an increase in TNF-alpha receptor gene expression in both skeletal muscle and adipose tissue.
|
Int J Oncol
16077938
|
12 |
3.079 |
2005 |
|
Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia.
|
Oncol Rep
15944798
|
30 |
2.662 |
2005 |
|
Interleukin-15 decreases lipid intestinal absorption.
|
Int J Mol Med
15870900
|
3 |
2.341 |
2005 |
|
Interleukin-15 decreases proteolysis in skeletal muscle: a direct effect.
|
Int J Mol Med
16077957
|
24 |
2.341 |
2005 |
|
Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future.
|
Nutrition
16043325
|
34 |
2.195 |
2005 |
|
Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway.
|
Cell Biol Int
15951205
|
65 |
1.831 |
2005 |
|
Cancer-associated malnutrition.
|
Eur J Oncol Nurs
16437757
|
87 |
1.826 |
2005 |
|
Overexpression of UCP3 in both murine and human myotubes is linked with the activation of proteolytic systems: a role in muscle wasting?
|
Biochim Biophys Acta
16337086
|
3 |
0 |
2005 |
|
Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
|
Cancer Res
15374990
|
53 |
9.122 |
2004 |
|
Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.
|
FEBS Lett
15225634
|
35 |
3.623 |
2004 |
|
The systemic inflammatory response is involved in the regulation of K(+) channel expression in brain via TNF-alpha-dependent and -independent pathways.
|
FEBS Lett
15304346
|
8 |
3.623 |
2004 |
|
Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
|
Int J Biochem Cell Biol
15743680
|
61 |
3.505 |
2004 |
|
Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients.
|
Int J Oncol
15138597
|
46 |
3.079 |
2004 |
|
The pharmacological treatment of cachexia.
|
Curr Drug Targets
15058312
|
10 |
3.061 |
2004 |
|
Plasma from pregnant rats has anti-tumoural activity.
|
Oncol Rep
15375517
|
0 |
2.662 |
2004 |
|
Sepsis induces DNA fragmentation in rat skeletal muscle.
|
Eur Cytokine Netw
14715419
|
5 |
2.364 |
2004 |
|
Effect of c-ski overexpression on the development of cachexia in mice bearing the Lewis lung carcinoma.
|
Int J Mol Med
15375607
|
2 |
2.341 |
2004 |
|
Rat liver lipogenesis is modulated by interleukin-15.
|
Int J Mol Med
15138618
|
7 |
2.341 |
2004 |
|
Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients.
|
Eur Respir J
12765422
|
38 |
10.569 |
2003 |
|
Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody.
|
Cell Death Differ
12934074
|
18 |
8.339 |
2003 |
|
Reduced protein degradation rates and low expression of proteolytic systems support skeletal muscle hypertrophy in transgenic mice overexpressing the c-ski oncogene.
|
Cancer Lett
14568169
|
3 |
6.375 |
2003 |
|
Catabolic mediators as targets for cancer cachexia.
|
Drug Discov Today
12963320
|
5 |
6.369 |
2003 |
|
Cytokines in the pathogenesis of cancer cachexia.
|
Curr Opin Clin Nutr Metab Care
12806213
|
58 |
4.023 |
2003 |
|
Impaired voltage-gated K+ channel expression in brain during experimental cancer cachexia.
|
FEBS Lett
12586336
|
8 |
3.623 |
2003 |
|
Cancer cachexia: the molecular mechanisms.
|
Int J Biochem Cell Biol
12565701
|
31 |
3.505 |
2003 |
|
Tumour necrosis factor-alpha uncouples respiration in isolated rat mitochondria.
|
Cytokine
12946099
|
10 |
3.488 |
2003 |
|
Muscle ubiquitin m-rNA levels in patients with end-stage renal disease on maintenance hemodialysis.
|
J Nephrol
12455723
|
4 |
2.153 |
2003 |
|
[Congenital absence of the inferior vena cava as a risk factor for pulmonar thromboembolism].
|
An Med Interna
12911014
|
0 |
0 |
2003 |
|
TNF-alpha modulates cytokine and cytokine receptors in C2C12 myotubes.
|
Cancer Lett
11741746
|
12 |
6.375 |
2002 |
|
Effects of the phosphodiesterase-IV inhibitor EMD 95832/3 on tumour growth and cachexia in rats bearing the Yoshida AH-130 ascites hepatoma.
|
Cancer Lett
12406548
|
0 |
6.375 |
2002 |
|
TNF-alpha is involved in activating DNA fragmentation in skeletal muscle.
|
Br J Cancer
11953838
|
19 |
6.176 |
2002 |
|
Branched-chain amino acids: a role in skeletal muscle proteolysis in catabolic states?
|
J Cell Physiol
12012323
|
7 |
4.08 |
2002 |
|
Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders.
|
Exp Cell Res
12372339
|
58 |
3.546 |
2002 |
|
The role of uncoupling proteins in pathophysiological states.
|
Biochem Biophys Res Commun
12054495
|
27 |
2.466 |
2002 |
|
Direct effects of tumor necrosis factor alpha (TNF-alpha) on murine skeletal muscle cell lines. Bimodal effects on protein metabolism.
|
Eur Cytokine Netw
11566620
|
6 |
2.364 |
2002 |
|
Tumor necrosis factor-alpha exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells.
|
Biochim Biophys Acta
11853880
|
17 |
0 |
2002 |
|
Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue.
|
Biochim Biophys Acta
11960686
|
35 |
0 |
2002 |
|
TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis.
|
Int J Obes Relat Metab Disord
12032749
|
25 |
0 |
2002 |
|
Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease.
|
Am J Respir Crit Care Med
11673195
|
23 |
13.204 |
2001 |
|
Cancer cachexia: a therapeutic approach.
|
Med Res Rev
11135301
|
18 |
8.763 |
2001 |
|
Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model.
|
Cancer Lett
11323096
|
23 |
6.375 |
2001 |
|
Hyperlipemia: a role in regulating UCP3 gene expression in skeletal muscle during cancer cachexia?
|
FEBS Lett
11566186
|
8 |
3.623 |
2001 |
|
Insulin and cancer (Review).
|
Int J Oncol
11251161
|
26 |
3.079 |
2001 |
|
Increased muscle ubiquitin mRNA levels in gastric cancer patients.
|
Am J Physiol Regul Integr Comp Physiol
11294777
|
35 |
2.982 |
2001 |
|
Metabolic interrelationships between liver and skeletal muscle in pathological states.
|
Life Sci
11531159
|
6 |
2.936 |
2001 |
|
Hepatic transport of gluconeogenic substrates during tumor growth in the rat.
|
Cancer Invest
11338881
|
0 |
2.39 |
2001 |
|
Increased uncoupling protein-2 gene expression in brain of lipopolysaccharide-injected mice: role of tumour necrosis factor-alpha?
|
Biochim Biophys Acta
11341972
|
7 |
0 |
2001 |
|
Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control.
|
Biochim Biophys Acta
11287118
|
47 |
0 |
2001 |
|
LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha.
|
Blood
10845916
|
105 |
13.164 |
2000 |
|
Lack of effect of the cytokine suppressive agent FR167653 on tumour growth and cachexia in rats bearing the Yoshida AH-130 ascites hepatoma.
|
Cancer Lett
10893448
|
1 |
6.375 |
2000 |
|
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.
|
Br J Cancer
10945502
|
49 |
6.176 |
2000 |
|
Short-term effects of leptin on skeletal muscle protein metabolism in the rat.
|
J Nutr Biochem
11091097
|
9 |
4.518 |
2000 |
|
Branched-chain amino acids inhibit proteolysis in rat skeletal muscle: mechanisms involved.
|
J Cell Physiol
10911370
|
12 |
4.08 |
2000 |
|
Lipids: A key role in multidrug resistance? (Review).
|
Int J Oncol
10717249
|
12 |
3.079 |
2000 |
|
DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia?
|
Biochem Biophys Res Commun
10753659
|
20 |
2.466 |
2000 |
|
The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting.
|
Eur Cytokine Netw
11125297
|
5 |
2.364 |
2000 |
|
Leptin expression in colorectal and breast cancer patients.
|
Int J Mol Med
10719061
|
62 |
2.341 |
2000 |
|
[The role of tumor necrosis factor in the control of fat reserve and obesity].
|
Med Clin (Barc)
10846690
|
0 |
1.125 |
2000 |
|
Does the mechanism responsible for TNF-mediated insulin resistance involve the proteasome?
|
Med Hypotheses
10859639
|
1 |
1.066 |
2000 |
|
Calpain-3 gene expression is decreased during experimental cancer cachexia.
|
Biochim Biophys Acta
10806331
|
10 |
0 |
2000 |
|
New mediators in cancer cachexia.
|
Nestle Nutr Workshop Ser Clin Perform Programme
11490571
|
0 |
0 |
2000 |
|
The role of cytokines in cancer cachexia.
|
Med Res Rev
10232651
|
50 |
8.763 |
1999 |
|
Leptin and tumor growth in rats.
|
Int J Cancer
10328224
|
7 |
6.513 |
1999 |
|
Mechanism for the increased skeletal muscle protein degradation in the obese Zucker rat.
|
J Nutr Biochem
15539297
|
8 |
4.518 |
1999 |
|
Tumour necrosis factor, a key role in obesity?
|
FEBS Lett
10371192
|
8 |
3.623 |
1999 |
|
Ubiquitin gene expression is increased in human muscle undergoing neurogenic involvement.
|
Neurochem Int
10213072
|
2 |
3.262 |
1999 |
|
Tumour growth and nitrogen metabolism in the host (Review).
|
Int J Oncol
10024680
|
4 |
3.079 |
1999 |
|
Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model.
|
Biochem Biophys Res Commun
9920811
|
44 |
2.466 |
1999 |
|
Leptin administration to lactating rats is unable to induce changes in lipid metabolism in white adipose tissue or mammary gland.
|
Eur J Obstet Gynecol Reprod Biol
10413235
|
1 |
1.666 |
1999 |
|
Prevention of cancer and cardiovascular diseases: a common strategy?
|
Med Res Rev
9578984
|
1 |
8.763 |
1998 |
|
Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1.
|
Cancer Lett
9751252
|
29 |
6.375 |
1998 |
|
Tumour necrosis factor-alpha does not cross the rat placenta.
|
Cancer Lett
9652799
|
2 |
6.375 |
1998 |
|
Different cytokines modulate ubiquitin gene expression in rat skeletal muscle.
|
Cancer Lett
9929164
|
26 |
6.375 |
1998 |
|
Catabolic proinflammatory cytokines.
|
Curr Opin Clin Nutr Metab Care
10565356
|
8 |
4.023 |
1998 |
|
Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice.
|
Mol Cell Endocrinol
9783914
|
36 |
3.754 |
1998 |
|
Short-term effects of leptin on lipid metabolism in the rat.
|
FEBS Lett
9714545
|
3 |
3.623 |
1998 |
|
Skeletal muscle UCP2 and UCP3 gene expression in a rat cancer cachexia model.
|
FEBS Lett
9801160
|
25 |
3.623 |
1998 |
|
In the rat, tumor necrosis factor alpha administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle: a possible mechanism for cytokine-induced thermogenesis?
|
FEBS Lett
9872400
|
13 |
3.623 |
1998 |
|
Tumor growth influences skeletal muscle protein turnover in the pregnant rat.
|
Pediatr Res
9475293
|
0 |
2.882 |
1998 |
|
The involvement of the ubiquitin system in Alzheimer's disease (review).
|
Int J Mol Med
9854137
|
1 |
2.341 |
1998 |
|
Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients.
|
Int J Mol Med
9854146
|
22 |
2.341 |
1998 |
|
Leptin levels and gene expression during the perinatal phase in the rat.
|
Eur J Obstet Gynecol Reprod Biol
9846722
|
0 |
1.666 |
1998 |
|
[Role of the ubiquitin system in the etiology of cancer and other diseases].
|
Med Clin (Barc)
9834917
|
1 |
1.125 |
1998 |
|
[Treatment of dysphagia of malignant origin with the endoprosthesis of Strecker].
|
Med Clin (Barc)
9672865
|
1 |
1.125 |
1998 |
|
Host metabolism: a target in clinical oncology?
|
Med Hypotheses
9848470
|
0 |
1.066 |
1998 |
|
Was tumour necrosis factor-alpha responsible for the fetal malformations associated with thalidomide in the early 1960s?
|
Med Hypotheses
9690766
|
4 |
1.066 |
1998 |
|
[Wallstent endoprostheses implanted by fluoroscopic guidance in the palliative treatment of malignant esophageal obstructions and esophago-tracheal fistulas].
|
Nutr Hosp
9617174
|
1 |
0.747 |
1998 |
|
The metabolic basis of cancer cachexia.
|
Med Res Rev
9276862
|
37 |
8.763 |
1997 |
|
The ubiquitin system: a role in disease?
|
Med Res Rev
9057163
|
1 |
8.763 |
1997 |
|
TNF and pregnancy: the paradigm of a complex interaction.
|
Cytokine Growth Factor Rev
9462484
|
10 |
6.794 |
1997 |
|
Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth.
|
Cancer Lett
9097986
|
11 |
6.375 |
1997 |
|
Sequential changes in lipoprotein lipase activity and lipaemia induced by the Yoshida AH-130 ascites hepatoma in rats.
|
Cancer Lett
9215859
|
7 |
6.375 |
1997 |
|
Journey from cachexia to obesity by TNF.
|
FASEB J
9271359
|
14 |
5.498 |
1997 |
|
Lipid metabolism in tumour-bearing mice: studies with knockout mice for tumour necrosis factor receptor 1 protein.
|
Mol Cell Endocrinol
9324050
|
11 |
3.754 |
1997 |
|
Cancer cachexia.
|
Int J Oncol
21533414
|
1 |
3.079 |
1997 |
|
Lipogenesis in rat tissues following carbohydrate refeeding: spleen lipogenesis is modulated by insulin.
|
Mol Cell Biochem
9350046
|
0 |
2.669 |
1997 |
|
TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles.
|
Biochem Biophys Res Commun
9016756
|
35 |
2.466 |
1997 |
|
Is TNF really involved in cachexia?
|
Cancer Invest
9028389
|
4 |
2.007 |
1997 |
|
Neutral amino acid transport in placental plasma membrane vesicles in the late pregnant rat. Evidence for a B0-like transport system.
|
Eur J Obstet Gynecol Reprod Biol
9031965
|
2 |
1.666 |
1997 |
|
[Metabolic host-tumor relationships during perinatal phase].
|
Med Clin (Barc)
9289543
|
0 |
1.125 |
1997 |
|
[Percutaneous implant of Hickman catheters and reservoirs. Long-term experience].
|
Rev Clin Esp
9547192
|
0 |
0.971 |
1997 |
|
Anti-TNF treatment does not reverse the abnormalities in lipid metabolism of the obese Zucker rat.
|
Am J Physiol
9142888
|
6 |
0 |
1997 |
|
The increased skeletal muscle protein turnover of the streptozotocin diabetic rat is associated with high concentrations of branched-chain amino acids.
|
Biochem Mol Med
9232202
|
17 |
0 |
1997 |
|
The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states.
|
Trends Pharmacol Sci
8763200
|
26 |
12.797 |
1996 |
|
Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486.
|
Cancer Lett
8564931
|
9 |
6.375 |
1996 |
|
alpha-Adrenergic receptors may contribute to the hypertriglyceridemia associated with tumour growth.
|
Cancer Lett
9018104
|
2 |
6.375 |
1996 |
|
Tumour growth and fetal uptake of amino acids in the pregnant rat.
|
Eur J Cancer
8869108
|
0 |
6.029 |
1996 |
|
Tumour growth results in changes in placental amino acid transport in the rat: a tumour necrosis factor alpha-mediated effect.
|
Biochem J
8546713
|
5 |
3.797 |
1996 |
|
Lipid metabolism in rats bearing the Yoshida AH-130 ascites hepatoma.
|
Mol Cell Biochem
8974077
|
5 |
2.669 |
1996 |
|
Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats.
|
Biochem Biophys Res Commun
8630016
|
12 |
2.466 |
1996 |
|
Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.
|
J Clin Invest
7738199
|
29 |
12.784 |
1995 |
|
TNF and AIDS: two sides of the same coin?
|
Med Res Rev
8558990
|
1 |
8.763 |
1995 |
|
Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis.
|
Int J Cancer
7705927
|
22 |
6.513 |
1995 |
|
Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130).
|
Cancer Lett
7656241
|
7 |
6.375 |
1995 |
|
Lack of effect of eicosapentaenoic acid in preventing cancer cachexia and inhibiting tumor growth.
|
Cancer Lett
7585474
|
2 |
6.375 |
1995 |
|
The effects of tumour growth on circulating amino acids in the late pregnant rat.
|
Cancer Lett
7850769
|
1 |
6.375 |
1995 |
|
Enhanced leucine oxidation in rats bearing an ascites hepatoma (Yoshida AH-130) and its reversal by clenbuterol.
|
Cancer Lett
7750097
|
5 |
6.375 |
1995 |
|
Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).
|
Br J Cancer
7577459
|
3 |
6.176 |
1995 |
|
Administration of tumor necrosis factor-alpha results in a decreased placental transfer of amino acids in the rat.
|
Endocrinology
7628396
|
6 |
4.286 |
1995 |
|
Marked hyperlipidaemia in rats bearing the Yoshida AH-130 ascites hepatoma.
|
Biochem Soc Trans
8566392
|
1 |
2.765 |
1995 |
|
Metabolic effects of tumour necrosis factor-alpha on rat brown adipose tissue.
|
Mol Cell Biochem
7596346
|
3 |
2.669 |
1995 |
|
Lipopolysaccharide (LPS) increases the in vivo oxidation of branched-chain amino acids in the rat: a cytokine-mediated effect.
|
Mol Cell Biochem
7476939
|
1 |
2.669 |
1995 |
|
Amino acid uptake in skeletal muscle of rats bearing the Yoshida AH-130 ascites hepatoma.
|
Mol Cell Biochem
7476929
|
1 |
2.669 |
1995 |
|
Ubiquitin gene expression in skeletal muscle is increased during sepsis: involvement of TNF-alpha but not IL-1.
|
Biochem Biophys Res Commun
8554606
|
10 |
2.466 |
1995 |
|
The effects of tumour necrosis factor-alpha on circulating amino acids in the pregnant rat.
|
Cancer Lett
8187051
|
1 |
6.375 |
1994 |
|
Interleukin-6 does not activate protein breakdown in rat skeletal muscle.
|
Cancer Lett
8124660
|
13 |
6.375 |
1994 |
|
Alanine metabolism in rats bearing the Yoshida AH-130 ascites hepatoma.
|
Cancer Lett
7812930
|
0 |
6.375 |
1994 |
|
Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model.
|
Clin Sci (Lond)
7955912
|
15 |
4.936 |
1994 |
|
Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats.
|
FEBS Lett
8307200
|
27 |
3.623 |
1994 |
|
Ubiquitin gene expression in skeletal muscle is increased by tumour necrosis factor-alpha.
|
Biochem Biophys Res Commun
8003002
|
15 |
2.466 |
1994 |
|
Cytokines and diabetes: the final step? Involvement of TNF-alpha in both type I and II diabetes mellitus.
|
Horm Metab Res
7851865
|
5 |
2.268 |
1994 |
|
The effect of chronic tumour necrosis factor-alpha treatment on urinary nitrogen excretion in the rat.
|
Biochem Mol Biol Int
7981655
|
2 |
0 |
1994 |
|
Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.
|
J Clin Invest
8254032
|
76 |
12.784 |
1993 |
|
Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats.
|
J Natl Cancer Inst
8340946
|
20 |
12.589 |
1993 |
|
A flow cytometric study of the rat Yoshida AH-130 ascites hepatoma.
|
Cancer Lett
8402587
|
3 |
6.375 |
1993 |
|
Tumour necrosis factor-alpha alters the blood compartmentation of amino acids in the rat.
|
Cancer Lett
8402578
|
0 |
6.375 |
1993 |
|
Intestinal glucose absorption is lower in obese than in lean Zucker rats.
|
J Nutr
8505666
|
3 |
4.145 |
1993 |
|
Intestinal and hepatic nitrogen balance in the rat after the administration of an oral protein load.
|
Br J Nutr
8329349
|
1 |
3.706 |
1993 |
|
Tumour necrosis factor-alpha increases the ubiquitinization of rat skeletal muscle proteins.
|
FEBS Lett
8388807
|
37 |
3.623 |
1993 |
|
Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle.
|
Mol Cell Biochem
8264567
|
44 |
2.669 |
1993 |
|
Amino acid metabolism enzyme activities in the obese Zucker rat.
|
Cell Mol Biol (Noisy-le-grand)
8101120
|
0 |
0.92 |
1993 |
|
Alanine as a lipogenic precursor in isolated hepatocytes from obese Zucker rats.
|
Cell Mol Biol (Noisy-le-grand)
8220077
|
2 |
0.92 |
1993 |
|
The effects of endotoxin administration on blood amino acid concentrations: similarities with sepsis.
|
Cell Mol Biol (Noisy-le-grand)
8374505
|
0 |
0.92 |
1993 |
|
Chronic tumour necrosis factor-alpha treatment modifies protein turnover in rat tissues.
|
Biochem Mol Biol Int
8358333
|
6 |
0 |
1993 |
|
Effects of tumour necrosis factor-alpha on the enzymatic activities related to glucose metabolism.
|
Biochem Mol Biol Int
8358332
|
1 |
0 |
1993 |
|
A simple method for determining the rate of gastrointestinal transit in the rat.
|
Arch Int Physiol Biochim Biophys
7689354
|
2 |
0 |
1993 |
|
Interleukin-1 and beta-cell function: more than one second messenger?
|
Endocr Rev
1425486
|
4 |
15.745 |
1992 |
|
The role of cytokines in muscle wasting: its relation with cancer cachexia.
|
Med Res Rev
1435017
|
13 |
8.763 |
1992 |
|
The enzymatic activities of branched-chain amino acid catabolism in tumour-bearing rats.
|
Cancer Lett
1739948
|
2 |
6.375 |
1992 |
|
Effects of tumour necrosis factor-alpha (cachectin) on glucose metabolism in the rat. Intestinal absorption and isolated enterocyte metabolism.
|
Mol Cell Biochem
1513334
|
3 |
2.669 |
1992 |
|
Intestinal handling of a glucose gavage by the rat.
|
Mol Cell Biochem
1640935
|
4 |
2.669 |
1992 |
|
Amino acid metabolism in several tissues of the obese Zucker rat as indicated by the tissue accumulation of alpha-amino[1-14C]isobutyrate.
|
Mol Cell Biochem
1584204
|
0 |
2.669 |
1992 |
|
The DDT method: an alternative to the use of radiolabelled microspheres for the determination of regional blood flows in the rat.
|
Med Hypotheses
1625605
|
0 |
1.066 |
1992 |
|
Rat intestinal amino acid balances after the administration of an oral protein load.
|
Biochem Int
1558542
|
1 |
0 |
1992 |
|
In the rat, intestinal lymph carries a significant amount of ingested glucose into the bloodstream.
|
Arch Int Physiol Biochim Biophys
1382671
|
3 |
0 |
1992 |
|
Hepatic accumulation of alpha-aminoisobutyrate in the pregnant rat at term.
|
Biochem Int
1456946
|
0 |
0 |
1992 |
|
The metabolic fate of an oral 14C-alanine load in the obese Zucker rat.
|
Int J Obes Relat Metab Disord
1317831
|
0 |
0 |
1992 |
|
The role of insulin in the intestinal absorption of glucose in the rat.
|
Int J Biochem
1387623
|
1 |
0 |
1992 |
|
Short-term effects of carbon dioxide on carnation callus cell respiration.
|
Plant Physiol
16668209
|
7 |
6.456 |
1991 |
|
The energy state of tumor-bearing rats.
|
J Biol Chem
1993670
|
8 |
4.125 |
1991 |
|
Lipid metabolism in the obese Zucker rat. Disposal of an oral [14C]triolein load and lipoprotein lipase activity.
|
Biochem J
2012594
|
3 |
3.797 |
1991 |
|
Glucose handling by hepatocytes from obese Zucker rats.
|
Biosci Rep
1790318
|
0 |
2.906 |
1991 |
|
Effects of starvation on the tissular lipogenic rate in the obese Zucker rat.
|
Biochem Int
1781782
|
0 |
0 |
1991 |
|
Rat liver amino acid balances after the administration of an oral protein load.
|
Biochem Int
1804106
|
0 |
0 |
1991 |
|
The impairment of respiration by glycolysis in the Lewis lung carcinoma.
|
Cancer Lett
2157546
|
7 |
6.375 |
1990 |
|
Rat splanchnic net oxygen consumption, energy implications.
|
J Physiol
2129230
|
3 |
4.739 |
1990 |
|
The effects of tumour necrosis factor-alpha (cachectin) and tumour growth on hepatic amino acid utilization in the rat.
|
Biochem J
2310368
|
7 |
3.797 |
1990 |
|
The oxidation of leucine in tumour-bearing rats.
|
Biochem J
2111700
|
5 |
3.797 |
1990 |
|
[The molecular bases of the cachexia associated with cancer].
|
Med Clin (Barc)
2186226
|
1 |
1.125 |
1990 |
|
Why do cancer cells have such a high glycolytic rate?
|
Med Hypotheses
2142979
|
19 |
1.066 |
1990 |
|
Is there a role for lymph in intestinal glucose absorption?
|
Med Hypotheses
2292980
|
1 |
1.066 |
1990 |
|
Intestinal amino acid transport: an overview.
|
Int J Biochem
1980895
|
4 |
0 |
1990 |
|
The obese Zucker rat: a choice for fat metabolism 1968-1988: twenty years of research on the insights of the Zucker mutation.
|
Prog Lipid Res
2682670
|
30 |
10.583 |
1989 |
|
Appearance of circulating and tissue 14C-lipids after oral 14C-tripalmitate administration in the late pregnant rat.
|
Metabolism
2643750
|
5 |
5.777 |
1989 |
|
Metabolic effects of tumour necrosis factor-alpha (cachectin) and interleukin-1.
|
Clin Sci (Lond)
2680232
|
28 |
4.936 |
1989 |
|
Comparative effects of tumour necrosis factor-alpha (cachectin), interleukin-1-beta and tumour growth on amino acid metabolism in the rat in vivo. Absorption and tissue uptake of alpha-amino[1-14C]isobutyrate.
|
Biochem J
2789041
|
15 |
3.797 |
1989 |
|
Interleukin-1 and lipid metabolism in the rat.
|
Biochem J
2658976
|
15 |
3.797 |
1989 |
|
The oxidation of methylglyoxal by mammalian pyruvate dehydrogenase.
|
Arch Biochem Biophys
2757395
|
2 |
3.165 |
1989 |
|
Oxidation of branched-chain amino acids in tumor-bearing rats.
|
Biochem Soc Trans
2628069
|
2 |
2.765 |
1989 |
|
Effects of tumour necrosis factor on hepatic amino acid uptake.
|
Biochem Soc Trans
2628070
|
1 |
2.765 |
1989 |
|
The respiratory behavior of Lewis carcinoma cells--existence of a cyanide-resistant respiration.
|
Cancer Biochem Biophys
2776118
|
0 |
0 |
1989 |
|
Amino acid metabolism in tumour-bearing mice.
|
Biochem J
3342022
|
23 |
3.797 |
1988 |
|
The metabolic environment of cancer.
|
Mol Cell Biochem
3050448
|
20 |
2.669 |
1988 |
|
A nondestructive method for the measurement of radioactive 14CO2 in blood.
|
Anal Biochem
3142294
|
1 |
2.334 |
1988 |
|
Effects of a cafeteria diet and starvation of global 14C(U)-glucose disposal.
|
Biochem Int
3190717
|
0 |
0 |
1988 |
|
A sensitive direct calorimeter for small mammals.
|
J Biochem Biophys Methods
3235765
|
0 |
0 |
1988 |
|
Blood amino acid compartmentation in mice bearing Lewis lung carcinoma.
|
Cancer Res
3664471
|
7 |
9.122 |
1987 |
|
Gas chromatographic method for the estimation of acetone and its metabolites in biological samples.
|
J Chromatogr
3584376
|
2 |
0 |
1987 |
|
Effects of starvation and a high-energy diet on rat blood compartmentation of injected radioactive alanine and glucose.
|
Biochem Int
3566781
|
1 |
0 |
1987 |
|
The appearance of 2,3-butanediol in the chronic ethanol treated pregnant rat.
|
Drug Alcohol Depend
3816529
|
0 |
3.222 |
1986 |
|
The metabolism of acetone in the pregnant rat.
|
Biosci Rep
3580522
|
3 |
2.906 |
1986 |
|
Rat acetoacetate decarboxylase: its role in the disposal of 4C-ketone bodies by the fetus.
|
Horm Metab Res
3744292
|
2 |
2.268 |
1986 |
|
On the role of 2,3-butanediol in the metabolism of ethanol.
|
Med Hypotheses
3637617
|
0 |
1.066 |
1986 |
|
Simultaneous determination of ketone bodies in biological samples by gas chromatographic headspace analysis.
|
J Chromatogr Sci
3980662
|
2 |
0.984 |
1985 |
|
Rat acetoacetic acid decarboxylase inhibition by acetone.
|
Int J Biochem
4076528
|
2 |
0 |
1985 |
|
Ethanol and acetaldehyde concentrations in the rat foeto-maternal system after an acute ethanol administration given to the mother.
|
Arch Int Physiol Biochim
6085549
|
5 |
0 |
1984 |
|
Effects of insulin on the disposal of 14C-labelled very low density lipoprotein triglycerides in intact and hepatectomized rats.
|
Diabetologia
6345250
|
0 |
6.08 |
1983 |
|
Changes in lipid composition of plasma lipoproteins after total hepatectomy in the rat.
|
Arch Int Physiol Biochim
6176203
|
0 |
0 |
1981 |
|
Lipids and lipoproteins in maternal and fetus plasma in the rat.
|
Biol Neonate
7213867
|
11 |
0 |
1981 |
|
[Televised radioscopy and ultra-instantaneous photoradiography in the detection of infantile ulcus].
|
Rev Esp Enferm Apar Dig
6049177
|
0 |
0 |
1967 |
